VEGF Antikörper (N-Term)
Kurzübersicht für VEGF Antikörper (N-Term) (ABIN2384453)
Target
Alle VEGF Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 33-48, N-Term
-
Sequenz
- VDIFQEYPDE IEYIFK
-
Kreuzreaktivität
- Human, Ratte (Rattus)
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Rt
-
Produktmerkmale
- Vascular Endothelial Growth Factor (VEGF-A, Vascular Permeability Factor, VPF, VEGFA, VEGF)
-
Aufreinigung
- Purified by immunoaffinity chromatography.
-
Immunogen
- Synthetic peptide corresponding to aa33-48, VDIFQEYPDEIEYIFK, sequence at the N-terminal of human Vascular Endothelial Growth Factor. Species Sequence Homology: Mouse
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute with 100 μL sterile ddH2O.
-
Buffer
- Supplied as a lyophilized powder in 5 mg BSA, 0.9 mg sodium chloride, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg sodium azide.
-
Konservierungsmittel
- Sodium azide, Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- VEGF (Vascular Endothelial Growth Factor (VEGF))
-
Andere Bezeichnung
- Vascular Endothelial Growth Factor
-
UniProt
- P15692
Target
-